title: Inflammatory bowel disease.
abstract: Inflammatory bowel diseases (IBDs) encompass ulcerative colitis, Crohn's disease, and indeterminate colitis, all of which are characterized by remission and exacerbation of gastrointestinal symptoms, and a variety of extraintestinal manifestations including those affecting the oral cavity. Although not particularly a cause for mortality, inflammatory bowel diseases are associated with significant morbidity and impact on the quality of life. This article reviews clinical presentation, diagnostic criteria, and therapeutic modalities for the 2 main types of inflammatory bowel disease and discusses manifestations of these conditions in the oral cavity. The role of the oral health care provider in timely recognition and referral for medical work-up as well as management of oral complaints is also emphasized.
authors.affiliation: New Jersey Dental School, University of Medicine & Dentistry of New Jersey, Newark, NJ, USA. fatahza@umdnj.edu
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Fatahzadeh
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005928:Glossitis / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D009059:Mouth Diseases / Q000209:etiology*; D052016:Mucositis / Q000209:etiology; D019226:Oral Ulcer / Q000209:etiology; D011788:Quality of Life; D013280:Stomatitis / Q000209:etiology
chemical_list: D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents